Clinical Trials Browser

Metastatic Pancreatic Adenocarcinoma × Oxaliplatin × Clear all

NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Phase 1/2 Completed

126 enrolled 19 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01729481 2017-07-19

ML22774

Phase 2 Unknown

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma